Results 131 to 140 of about 15,602,619 (166)
Some of the next articles are maybe not open access.

Severe hemolysis following administration of Rho(D) immune globulin in an ITP patient associated with anti-C

Blood, 2006
In a recent issue of Blood, Gaines[1][1] reported on disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following intravenous administration of Rho(D) immune globulin as a treatment for immune thrombocytopenic purpura (ITP).
Joseph Schwartz   +2 more
openaire   +1 more source

Clinical evaluation of Rho(D) immune globulin (human) in Canada.

Canadian Medical Association journal, 1970
-During 1966, clinical trials were conducted in three Canadian centres to determine the safety and efficacy of Rh(0)(D) immune globulin (human) in preventing isoimmunization by the Rh(0)(D) antigen in Rh-negative women delivering ABO-compatible Rh-positive infants.The candidates were randomly divided into control and treated groups; the treated mothers
E C, Bryant   +6 more
openaire   +1 more source

Non-evidence-based use of Rho(D) immune globulin for threatened abortion by family practice and obstetric faculty physicians.

The Journal of reproductive medicine, 2003
To examine the practice patterns and differences between faculty members in obstetrics and gynecology (OB/G) and family practice (FP) residency programs in administering Rho(D) immune globulin (RhIG) for threatened abortion.A questionnaire was mailed to 50% (222) of all FP residencies and 100% (267) of OB/G programs in the United States.
Alicia M, Weissman   +3 more
openaire   +2 more sources

Dermatofibrosarcoma protuberans arising at a Rho(D) immune globulin injection site.

Cutis, 2013
Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue tumor arising in the dermis. It is notorious for high rates of local recurrence despite its low metastatic potential. Although the etiology is unknown, DFSP often is considered to arise within scars and at sites of prior vaccination or trauma. Clinically, DFSP can be highly variable and mimic
Stefanie A, Hirano, Cyndi M, Torosky
openaire   +1 more source

Acute Hemolytic Reactions Reported in ITP Patients Treated with Rho (D) Immune Globulin: Symptom Onset and Does Prior Exposure Lessen the Risk?

Blood, 2011
Abstract Abstract 4670 BACKGROUND: Acute hemolytic reactions (AHR) associated with administration of Rho (D) Immune Globulin (RhIG; WinRho® SDF, Cangene Corporation, Winnipeg, Canada) have been infrequently reported during the previous 16 years.
Carmen Muller   +3 more
openaire   +1 more source

SERUM SICKNESS REACTION FOLLOWING RHO(D) IMMUNE GLOBULIN

Annals of Allergy, Asthma & Immunology, 2023
Y. Ghiasi, T. Carr
openaire   +1 more source

Reduced dose of Rho(D) immune globulin following induced first-trimester abortion.

American journal of obstetrics and gynecology, 1977
A double-blind study of women after first-trimester abortion supports the efficacy of low-dose Rho(D) immune globulin (human) in the prevention of Rh sensitization. Twenty-seven per cent of patients demonstrated a fetomaternal blood leak based on Kleihauer-Betke stains.
P A, Hensleigh   +5 more
openaire   +1 more source

The Prenatal Use Of Rho(D) Immune Globulin

MCN, The American Journal of Maternal/Child Nursing, 1984
R M, Hammer, E J, Bower, L J, Messina
openaire   +2 more sources

Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment.

Neuro endocrinology letters, 2008
Many formulations of Thimerosal (49.55% mercury by weight)-containing Rho(D) immune globulins (TCRs) were routinely administered to Rh-negative mothers in the US prior to 2002.It was hypothesized: (1) if prenatal Rho(D)-immune globulin preparation exposure was a risk factor for neurodevelopmental disorders (NDs) then more children with NDs would have ...
David A, Geier   +4 more
openaire   +1 more source

• CNS Effects of Antiepileptic Drugs/• Depression and Suicide with Accutane/• Hepatitis Due to Celecoxib: An Allergic Reaction?/• Problem with Antabuse/• Renal Failure with Intravenous Rho(D)Immune Globulin/• ACE Inhibitor Causes Hyperkalemia and Rare Type of Paralysis

Hospital Pharmacy, 2001
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
openaire   +1 more source

Home - About - Disclaimer - Privacy